SENSORINEURAL HEARING IMPAIRMENT (SNHI) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY AT A TERTIARY CARE HOSPITAL IN PAKISTAN
DOI:
https://doi.org/10.52764/jms.26.34.1.6Keywords:
Pure Tone Audiometry, Sensorineural Hearing Impairment, and Diabetes MellitusAbstract
OBJECTIVE: To assess the prevalence of sensorineural impairment in patients with type 2 diabetes and to explore the relationship between hearing loss and variables such as age, gender, HbA1C, and duration of diabetes.
MATERIALS AND METHODS: This cross-sectional study was conducted from April to August 2025 and included patients with type 2 diabetes mellitus. Data were collected using the Hearing Handicap Inventory for Adults (HHIA) to screen for diabetes among individuals with hearing impairment. A non-probability convenience sampling method was used. Pure-tone audiometry (PTA) was employed to assess hearing. SPSS Statistics version 20 was used for data analysis. The chi-square test was used to assess associations, with results presented as frequencies and percentages.
RESULTS: The study included 195 patients with Type 2 Diabetes mellitus aged 25-65 years. Of these, 7.7% were found to have sensorineural hearing loss, which primarily affects higher frequencies (2-4 kHz) and is usually mild to moderate. Additionally, it was found that sensorineural hearing impairment was significantly (p<0.005) associated with diabetes duration, hypertension, poor glycemic control, and chronic kidney disease.
CONCLUSION: In this study, SNHI was found in only a small portion of diabetic patients. HHIA responses showed that most participants faced minimal hearing-related issues, while a significant link was observed between SNI and the duration of diabetes, poor blood sugar control, hypertension, and chronic kidney disease.
KEYWORDS: Pure Tone Audiometry, Sensorineural Hearing Impairment, and Diabetes Mellitus
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Faheem ul Hassan, Sundus Huma, Farah Naz Afridi, Shahab Zaib, Adeela Mustafa, Abu Huraira
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
